Journal
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Volume 99, Issue -, Pages 186-196Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.biocel.2018.04.013
Keywords
alpha v beta 6 integrin; TGF-beta; Fibrosis; Cancer; Periodontal disease; Amelogenesis imperfecta; Inflammation
Categories
Funding
- Canadian Institutes of Health Research [CIHR MOP-97908, MOP-115203, CIHR PJT153223]
- Natural Sciences and Engineering Research Council of Canada [NSERC RGPIN-2017-05633, NSERC RGPIN-2017-05765]
- University of British Columbia (Joseph Tonzetich Fellowship)
Ask authors/readers for more resources
Integrins are cell surface receptors that traditionally mediate cell-to-extracellular matrix and cell-to-cell adhesion. They can, however, also bind a large repertoire of other molecules. Integrin alpha v beta 6 is exclusively expressed in epithelial cells where it can, for example, serve as a fibronectin receptor. However, its hallmark function is to activate transforming growth factor-beta 1 (TGF-beta 1) to modulate innate immune surveillance in lungs and skin and along the gastrointestinal tract, and to maintain epithelial stem cell quiescence. The loss of alpha v beta 6 integrin function in mice and humans leads to an altered immune response in lungs and skin, amelogenesis imperfecta, periodontal disease and, in some cases, alopecia. Elevated alpha v beta 6 integrin expression and aberrant TGF-beta 1 activation and function are associated with organ fibrosis and cancer. Therefore, alpha v beta 6 integrin serves as an attractive target for cancer imaging and for fibrosis and cancer therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available